Cyclosporin A and FK506 inhibit activation-induced cell death in the murine WEHI-231 B cell line.
The WEHI-231 B lymphoma cell line expresses the phenotype of immature B cells. Cross-linking of surface IgM induces programmed cell death (PCD) with typical features of apoptosis demonstrated by the decrease of cell DNA content, chromatin condensation, and nuclear fragmentation. Activation of protein kinase C (PKC) by phorbol esters was reported to protect WEHI-231 cells against apoptosis induced by ligation of antigen receptors. It was therefore hypothesized that PCD could result from a defect in PKC response with an imbalance in the phosphoinositide pathway in favor of Ca2+ mobilization. In support of this hypothesis, we show here that apoptosis can be readily triggered by the calcium ionophore ionomycin. Furthermore, pretreatment of cells with cyclosporin A or FK506 which inhibit selectively the phosphoprotein calcineurin, a calcium-and calmodulin-dependent serine/threonine phosphatase, protects WEHI-231 cells against apoptosis induced by ionomycin or ligation of surface IgM. Unlike phorbol esters, cyclosporin A did not impair the rise of intracellular Ca2+ induced by cross-linking of antigen receptors. Altogether, the data indicate that the phosphorylation status of yet undefined key cellular substrates controls the cellular response to calcium-dependent apoptotic signals in this B cell lymphoma.
Genestier
L
L
Laboratoire d'immunologie, INSERM U80 UCBL, Hôpital E. Herriot, Lyon, France.
Dearden-Badet
M T
MT
Bonnefoy-Berard
N
N
Lizard
G
G
Revillard
J P
JP
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D002118:Calcium / Q000494:pharmacology; D003432:Cross-Linking Reagents; D016572:Cyclosporine / Q000494:pharmacology*; D007075:Immunoglobulin M / Q000378:metabolism; D007166:Immunosuppressive Agents / Q000494:pharmacology; D015759:Ionomycin / Q000494:pharmacology; D016393:Lymphoma, B-Cell; D051379:Mice; D011090:Polyenes / Q000494:pharmacology; D011947:Receptors, Antigen, B-Cell / Q000378:metabolism; D015398:Signal Transduction; D020123:Sirolimus; D016559:Tacrolimus / Q000494:pharmacology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D003432:Cross-Linking Reagents; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D011090:Polyenes; D011947:Receptors, Antigen, B-Cell; D015759:Ionomycin; D016572:Cyclosporine; D013755:Tetradecanoylphorbol Acetate; D002118:Calcium; D020123:Sirolimus; D016559:Tacrolimus